QuickView for THY1;jsessionid=FDD5B82AA76874F95C4C52E4B660F284 (gene)

1. CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for …
2. An Anti-CD7 Antibody-Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leu…
3. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
4. Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblas…
5. Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplant…

There were no clinical trials for THY1;jsessionid=FDD5B82AA76874F95C4C52E4B660F284